Spinal Elements appoints Ron Lloyd as president and chief executive officer

Ron Lloyd

Spinal Elements has announced the appointment of Ronald (Ron) Lloyd as new president and chief executive officer. He succeeds co-founder and former president and CEO Jason Blain, who has served as a leader of the organisation since Spinal Elements’ inception as Quantum Orthopedics in 2003.

Prior to Spinal Elements, Lloyd served as president and CEO of Aziyo Biologics, an integrated regenerative medicine company and took the company public in 2020. Before Aziyo, Lloyd served as president of Hospital Therapies at Mallinckrodt Pharmaceuticals and has held senior leadership roles at Baxter International and at Abbott Laboratories.

Former CEO, Jason Blain, said: “Leading Spinal Elements has been the most rewarding and humbling experience of my professional career. I am thankful for all of the colleagues and friends with whom I had the pleasure to serve during those more than 19 years. I look forward to watching the Spinal Elements team flourish under Ron’s guidance in the coming months and years.”

Incoming CEO, Ron Lloyd, added: “I have been very impressed with the rich history of innovation here at Spinal Elements. We look forward to recognising and celebrating that history in 2023, our 20th year of operation. I look forward to applying my experience in commercial strategy to extending the reach of Spinal Elements’ portfolio of innovative solutions, including our novel MIS Ultra product line to a broader base of surgeon customers and patient recipients.”

Most recent releases within the MIS Ultra platform of products and procedural solutions are Karma MIS, the Luna XD multi-expandable interbody system, the Orbit discectomy system, and the Sapphire X ACDF system.

Matt Jennings, operating partner of Kohlberg and chairman of the board, commented: “We are thrilled to add Ron to the Spinal Elements leadership team. Ron brings to Spinal Elements an extensive track record of leadership across the medical device, biological products, pharmaceutical and nutritional products industries.

“Ron’s unique combination of commercial expertise and operational depth will help accelerate the next phase of growth at Spinal Elements. We thank Jason for his service to the company and appreciate his ongoing support to the team at Spinal Elements.”


Please enter your comment!
Please enter your name here